-
International Journal of Interferon, Cytokine and Mediator Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Dendritic cells in infectious disease, hypersensitivity, and autoimmunity
Review
(1896) Views (897) Full article downloads
Authors: Brenda Gonzalez, Carlos Guerra, Devin Morris, et al
Published Date November 2010
Volume 2010:2 Pages 137 - 147
DOI: http://dx.doi.org/10.2147/IJICMR.S11978
Brenda Gonzalez1,3, Carlos Guerra1, Devin Morris2, Dennis Gray1, Vishwanath Venketaraman11College of Osteopathic Medicine of the Pacific, 2Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona; 3California State Polytechnic University, Pomona, CA, USA
Abstract: Dendritic cells are thought to direct subsequent T lymphocyte-driven adaptive immune responses (Th1/Th2) following interaction with either endogenous or exogenous antigens. These cells have an integral role in the pathogenesis of countless infectious diseases, but their role is most vividly illustrated in human immunodeficiency virus/acquired immunodeficiency syndrome and tuberculosis. Dendritic cells can arise from either myeloid or lymphoid progenitors, but the former is more common. Of particular importance are myeloid-related dendritic cells, plasmacytoid dendritic cells, infiltrating inflammatory dendritic epidermal cells, and Langerhans cells. Myeloid-related dendritic cells resemble typical monocytes, but produce cytokines that favor the cell-mediated immune response. Plasmacytoid dendritic cells resemble plasma cells, but have additional antigen-processing capabilities, and their major role is to produce interferon alpha and beta in response to viral infections. Inflammatory dendritic epidermal cells express the highest concentration of costimulatory molecules known in any cell lineage. Langerhans cells are the chief dendritic cells of the skin, and play a pivotal role in hypersensitivity and autoimmune pathologies, such as atopic dermatitis and psoriasis. Lastly, reduced glutathione has been implicated in modulation of the cytokine profiles of professional antigen-presenting cells, and holds promise as a future immunotherapeutic agent. This review discusses in detail the origin, characteristics, and overall functions of different types of dendritic cells. Furthermore, we have also highlighted the role of dendritic cells in infectious diseases and autoimmune diseases, with special reference to human immunodeficiency virus, tuberculosis, atopic dermatitis, and psoriasis.
Keywords: dendritic cell, autoimmunity, tuberculosis, HIV, innate and adaptive immunity
Other articles by Dr Vishwanath Venketaraman
Readers of this article also read:
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Cytokines and sympathy: the control of regulatory T cells
γδ T cells and IL-17/IL-17R signaling axis in CNS inflammation
Erratum
A case of recurrent bloody tears
Adhesion of osteoblasts to a nanorough titanium implant surface
Comparison of Dilapan-S and laminaria for cervical priming before surgical pregnancy termination at 17–22 weeks' gestation
The role of tumor necrosis factor-receptors in pregnancy with normal and adverse outcome
Depression and pegylated interferon-based hepatitis C treatment
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Evolution of a domain conserved in microtubule-associated proteins of eukaryotes
- Is gene activity in plant cells affected by UMTS-irradiation? A whole genome approach
- Discrimination between biological interfaces and crystal-packing contacts
- A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells




